Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2007
04/25/2007EP1776357A1 Hydroxyamide compounds having activity as inhibitors of histone deacetylase (hdac)
04/25/2007EP1776356A1 Alkyl-and piperidine-substituted benzimidazole-derivates
04/25/2007EP1776355A2 Potassium channel inhibitors
04/25/2007EP1776344A2 Quinoline derivatives as neurokinin receptor antagonists
04/25/2007EP1776339A2 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
04/25/2007EP1675593A4 Process for making sterile aripiprazole of desired mean particle size
04/25/2007EP1567500B1 Resolution of mefloquine with o,o-di-p-aroyltartaric acid
04/25/2007EP1537100B1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
04/25/2007EP1408950B1 Methods of treating cytokine mediated diseases
04/25/2007EP1305294B1 Imidazolyl derivatives
04/25/2007EP1210336B1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
04/25/2007EP1209151B1 4-substituted piperidine derivatives
04/25/2007EP1200824B1 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
04/25/2007EP1104417B1 Improved omeprazole process and compositions thereof
04/25/2007EP1040101B1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
04/25/2007EP1024138B1 Pyrazole derivatives
04/25/2007EP0949865A4 The use of cd4-binding small molecules to inhibit immune responses
04/25/2007EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors
04/25/2007CN1953976A Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
04/25/2007CN1953975A 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists
04/25/2007CN1953974A Pyrimidine derivatives for the treatment of abnormal cell growth
04/25/2007CN1953972A 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
04/25/2007CN1953747A Diphenyl-indol-2-on compounds and their use in the treatment of cancer
04/25/2007CN1951939A Novel pyrrole derivatives as pharmaceutical agents
04/25/2007CN1951937A Process for preparing argatroban hydrate
04/25/2007CN1951936A Argatroban separation method
04/25/2007CN1951918A Substituted pyridine herbicides
04/25/2007CN1951917A Pyridinone derivatives for treatment of atherosclerosis
04/25/2007CN1312150C Salt of (s)-pantoprazole hydrates, drug and use thereof
04/25/2007CN1312140C Lipid lowering biphenylcarboxamides
04/25/2007CN1312138C Novel azoles having an insecticidal action
04/25/2007CN1312136C Triazole derivatives as tachykinin receptor antagonists
04/25/2007CN1312134C 5-phenylpyrimidines, fungicide compositions comprising the same, method for producing and use thereof
04/25/2007CN1312131C Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent
04/25/2007CN1312127C 2-cyano-4-fluoropyrrolidine derivative or its salt
04/24/2007US7208605 Functionalized ionic liquids, and methods of use thereof
04/24/2007US7208604 Methods for the synthesis of alfentanil, sufentanil, and remifentanil
04/24/2007US7208603 Synthesis method and intermediates of pyridin-2-yl-methylamine
04/24/2007US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein.
04/24/2007US7208597 Such as 2-tert-butyl-4-n-octylamino-6-pyrid-2-yl-1,3,5-triazine; for treating or preventing biofilms on human tooth surfaces and oral mucosa
04/24/2007US7208586 Azo dye one and azo dye two are linked with a linking chain and both dyes conatin a cationic heteroaromatic ring
04/24/2007US7208527 Potassium channel modulators
04/24/2007US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
04/24/2007US7208504 Bicyclic inhibitors of hormone sensitive lipase
04/24/2007US7208499 Pyrimidine derivatives for the treatment of abnormal cell growth
04/24/2007US7208497 Substituted piperazines and diazepanes
04/24/2007US7208495 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof
04/24/2007US7208493 Vasculostatic agents and methods of use thereof
04/24/2007US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones
04/24/2007US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling
04/24/2007CA2281545C N-heterocyclic derivatives as nos inhibitors
04/24/2007CA2197793C New multimerizing agents
04/24/2007CA2194503C 2-[(dihydro)pyrazol-3'-yloxymethylene]anilides, their preparation and their use
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/19/2007WO2007044729A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
04/19/2007WO2007044515A1 Azetidines as mek inhibitors for the treatment of proliferative diseases
04/19/2007WO2007044215A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators
04/19/2007WO2007044085A2 Heteroaryl compounds and their uses as therapeutic agents
04/19/2007WO2007043677A1 Hydrazide compound and pesticidal use of the same
04/19/2007WO2007043653A1 Benzimidazole-5-carboxamide derivative
04/19/2007WO2007043484A1 Carbazole-containing amine compound and use thereof
04/19/2007WO2007043457A1 Triarylcarboxylic acid derivative
04/19/2007WO2007043426A1 Dermatitis remedies
04/19/2007WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007WO2007042912A2 Heterocyclic compounds as pstat3/il-6 inhibitors
04/19/2007WO2007042810A1 Pyrimidine derivatives for the treatment of cancer
04/19/2007WO2007042806A1 Pyrimidine derivatives for the treatment of cancer
04/19/2007WO2007042786A2 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors
04/19/2007WO2007042669A2 Derivatives of 4-amino-quinazoline, preparation method thereof and use of same in therapeutics
04/19/2007WO2007042668A1 Derivatives of 1-amino-isoquinoline, preparation method thereof and use of same in therapeutics in the treatment of a dysfunction associated with mch receptor 1
04/19/2007WO2007042660A2 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof
04/19/2007WO2007042546A1 Imidazole derivatives for the treatment of anxiety and related diseases
04/19/2007WO2007042545A1 Imidazole derivatives and their use for modulating the gaba-a receptor complex
04/19/2007WO2007042325A1 Antibacterial active 5-chinolin derivative
04/19/2007WO2007042321A2 Kinase inhibitors
04/19/2007WO2007042250A1 Prolinamide derivatives as sodium channel modulators
04/19/2007WO2007041790A1 Salts of proton pump inhibitors and process for preparing same
04/19/2007WO2007024833B1 Anthranilamides for controlling invertebrate pests
04/19/2007WO2007020502A3 Cannabinoid receptor ligands and uses thereof
04/19/2007WO2007020050A3 Bicyclic bisamide derivatives and use thereof as insecticides
04/19/2007WO2007020050A2 Bicyclic bisamide derivatives and use thereof as insecticides
04/19/2007WO2007015923A3 Benzimidazoles useful as inhibitors of protein kinases
04/19/2007WO2007009758A3 2r,4s) -4- (4-acetyl-3-hydroxy-1-piperazinyl) -n- { (1r) -1- [3, 5-bis (trifluoromethyl) phenyl] ethyl} -2- (4-fluoro-2-methylphenyl) -n-methyl-1-piperidine-carboxamide as tachykinin receptor antagonist
04/19/2007WO2007005887A3 Androgen receptor modulator compounds, compositions and uses thereof
04/19/2007WO2006131340A3 Pyrrolones that act as peptide deformylase (pdf) inhibitors
04/19/2007WO2006128693A3 2 -oxo-i -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system
04/19/2007WO2006116157A3 Dipeptidyl peptidase-iv inhibitors
04/19/2007WO2006103003A3 Substituted pyrazolyl oxyphenyl derivatives used as herbicides
04/19/2007WO2006074924A8 3,4,(5)-substituted tetrahvdropyridines
04/19/2007WO2006034317A3 Chemical compounds
04/19/2007US20070088165 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
04/19/2007US20070088159 Hydroxyalkyl cyclic diamine compounds
04/19/2007US20070088062 N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; keratinization disorder such as rosacea, acne, and psoriasis; potent inhibitors of the retinoic acid-metabolism; show little or no endocrinological side-effects;
04/19/2007US20070088054 Biphenyl derivatives
04/19/2007US20070088047 21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators
04/19/2007US20070088044 Quinazoline derivatives as antitumor agents
04/19/2007US20070088041 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals
04/19/2007US20070088037 Cancer and fibrotic diseases
04/19/2007US20070088033 Diaryl Substituted Pyridinones
04/19/2007US20070088032 Processes for the Preparation of Benzoimidazole Derivatives